New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients

Journal of Infectious Diseases

Volumn 182, Issue 1, 2000, Pages 36-42

  Pellegrin, Isabelle ^a,c   Garrigue, Isabelle ^a   Ekouevi, Didier ^b   Couzi, Lionel ^c   Merville, Pierre ^c   Merel, Patrick ^a   Chene, Geneviève ^b   Schrive, Marie Hélène ^a   Trimoulet, Pascale ^a   Lafon, Marie Edith ^a   Fleury, Hervé ^a  

^a Lab Virol   (France)

^b Departement d'Informatique Medicale   (France)

^c HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITY; ARTICLE; CELL COMPARTMENTALIZATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS SHEDDING;

ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; PHOSPHOPROTEINS; SENSITIVITY AND SPECIFICITY; VIRAL MATRIX PROTEINS;

EID: 0033912743     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315688     Document Type: Article

References (39)

1. 1. Ho M. Cytomegalovirus infection and indirect sequelae in the immunocompromised transplant patient. Transplant Proc 1991; 23(Suppl 1):2-7.
2. 2. Nevins TE, Dunn DL. Use of ganciclovir for cytomegalovirus infection. J Am Soc Nephrol 1992; 2(Suppl):S270-3.
3. 3. Farrugia E, Schwab TR. Management and prevention of cytomegalovirus infection after renal transplantation. Mayo Clin Proc 1992; 67:879-90.
4. 4. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 1992; 53:68-72.
5. 5. von Willebrand E, Petterson E, Ahonen J, Hayry P. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986; 42:364-7.
6. 6. Grundy JE, Ayles HM, McKeating JA, Butcher RG, Griffiths PD, Poulter LW. Enhancement of class I HLA antigen expression by cytomegalovirus: role in amplification of virus infection. J Med Virol 1988; 25:483-95.
7. 7. Pasternack MS, Medearis DN, Rubin NH. Cell-mediated immunity in experimental cytomegalovirus infection: a perspective. Rev Infect Dis 1990; 12(Suppl 7):S720-26.
8. 8. Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87:2725-9.
9. 9. Schäfer P, Braun RW, Möhring K, et al. Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested polymerase chain reaction and temperature gradient gel electrophoresis. J Gen Virol 1993; 74:2699-707.
10. 10. Zipeto D, Baldanti F, Zella D, et al. Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction. J Virol Methods 1993; 44:45-56.
11. 11. Gerna G, Furione M, Baldanti F, Sarasini A. Comparative quantitation of human cytomegalovirus (CMV) in blood leukocytes and plasma of transplant and AIDS patients. J Clin Microbiol 1994; 32:2709-17.
12. 12. Boivin G, Olson CA, Quirk MR, St-Cyr SM, Jordan MC. Quantitation of human cytomegalovirus glycoprotein H gene in cells using competitive PCR and a rapid fluorescence-based detection system. J Virol Methods 1995; 51:329-42.
13. 13. Zipeto D, Morris S, Hong C, et al. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol 1995; 33:2607-11.
14. 14. Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. J Clin Microbiol 1993; 31:2851-6.
15. 15. Storch GA, Buller RS, Bailey TC, et al. Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients. J Clin Microbiol 1994; 32:997-1003.
16. 16. Pellegrin I, Garrigue I, Binquet C, et al. Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients. J Clin Microbiol 1999; 37:3124-32.
17. 17. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28:495-503.
18. 18. Compton J. Nucleic acid sequence-based amplification. Nature 1991; 350: 91-2.
19. 19. Kievits T, van Gemen B, van Strijp D, et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods 1991; 35:273-86.
20. 20. Roeles F, Sillekens P, Tacken N, et al. Nuclisens CMV pp67: a new NASBA based amplification assay to detect late pp67 mRNA as an indicator for CMV replication [abstract 313]. 6th European Conference on Clinical Aspects and treatment of HIV infection (Hamburg, Germany), 11-15 October 1997.
21. 21. Grundy JE, Lui SF, Super M, et al. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 1988; 8603:132-5.
22. 22. Eriksson BM, Wirgart B, Claesson K, et al. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival. Clin Transplant 1996; 10: 494-502.
23. 23. The TH, van der Ploeg M, van den Berg AP, Vlieger AM, van der Giessen M, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes: a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992; 54:193-8.
24. 24. Meyer-König U, Serr A, von Laer D, et al. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients. J Infect Dis 1995; 171:705-9.
25. 25. Sharma AK, Taylor JD, Tong W, Brown MW, Sells RA, Bakran A. Utility of the pp65 antigenemia test in the diagnosis of cytomegalovirus (CMV) in renal transplant recipients. Transplant Proc 1997; 29:799.
26. 26. Boeckh M, Woogerd PM, Steven-Ayers T, Ray CG, Bowden RA. Factors influencing detection of quantitative cytomegalovirus antigenemia. J Clin Microbiol 1994; 32:832-4.
27. 27. Niubo J, Perez JL, Carvajal A, Ardanuy C, Martin R. Effect of delayed processing of blood samples on performance of cytomegalovirus antigenemia assay. J Clin Microbiol 1994; 32:1119-20.
28. 28. Schäfer P, Tenschert W, Gutensohn K, Laufs R. Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay. J Clin Microbiol 1997; 35:741-4.
29. 29. Boeckh M, Gallez-Hawkins GM, Myerson D, Zaia JA, Bowden RA. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation. Transplantation 1997; 64:108-13.
30. 30. Spector SA, Merrill R, Wolf D, Dankner WM. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol 1992; 30:2359-65.
31. 31. Brytting M, Xu W, Wahren B, Sundqvist VA. Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections. J Clin Microbiol 1992; 30:1937-41.
32. 32. Hansen KK, Ricksten A, Hofmann B, Norrild B, Olofsson S, Mathiesen L. Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS. J Infect Dis 1994; 170:1271-4.
33. 33. Patel R, Smith TF, Espy M, et al. Detection of cytomegalovirus DNA in serum of liver transplant recipients. J Clin Microbiol 1994; 32:1431-4.
34. 34. Schäfer P, Tenschert W, Cremaschi L, Gutensohn K, Laufs R. Utility of major leukocyte subpopulations for monitoring secondary cytomegalovirus infections in renal-allograft recipients by PCR. J Clin Microbiol 1998; 36:1008-14.
35. 35. Meyer T, Reischl U, Wolf H, Schüller C, Arndt R. Identification of active cytomegalovirus infection by analysis of immediate-early, early and late transcripts in peripheral blood cells of immunodeficient patients. Mol Cell Probes 1994; 8:261-71.
36. 36. Gaeta A, Nazzari C, Angeletti S, Lazzarini M, Mazzei E, Mancini C. Monitoring for cytomegalovirus infection in organ transplant recipients: analysis of pp65 antigen, DNA and late mRNA in peripheral blood leukocytes. J Med Virol 1997; 53:189-95.
37. 37. Roberts TC, Brennan DC, Buller RS, et al. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients. J Infect Dis 1998; 178:626-35.
38. 38. Kühn JE, Wendland T, Schäfer P, et al. Monitoring of renal allograft recipients by quantitation of human cytomegalovirus genomes in peripheral blood leukocytes. J Med Virol 1994; 44:398-405.
39. 39. Wolf DG, Spector SA. Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma. Transplantation 1993; 56:330-4.